{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:55:35Z","timestamp":1787766935932,"version":"build-2784847793"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s40272-024-00652-8","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T15:02:44Z","timestamp":1727449364000},"page":"753-765","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Effect of Levetiracetam and Valproic Acid Treatment on Anger and Attention Deficit Hyperactivity Disorder Clinical Features in Children and Adolescents with Epilepsy: A Prospective Study"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3834-9262","authenticated-orcid":false,"given":"Zeynep","family":"Vatansever P\u0131nar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9876-2454","authenticated-orcid":false,"given":"Safiye G\u00fcne\u015f","family":"Sa\u011fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5312-6681","authenticated-orcid":false,"given":"\u0130rem Damla","family":"\u00c7imen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3855-7280","authenticated-orcid":false,"given":"Yakup","family":"\u00c7a\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"issue":"3","key":"652_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3109\/01460869509087271","volume":"18","author":"CD Spielberger","year":"1995","unstructured":"Spielberger CD, Reheiser EC, Sydeman SJ. Measuring the experience, expression, and control of anger. Issues Compr Pediatr Nurs. 1995;18(3):207\u201332. https:\/\/doi.org\/10.3109\/01460869509087271.","journal-title":"Issues Compr Pediatr Nurs"},{"issue":"6","key":"652_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3109\/01460869509087271","volume":"20","author":"TM Starner","year":"2004","unstructured":"Starner TM, Peters RM. Anger expression and blood pressure in adolescents. J Sch Nurs. 2004;20(6):335\u201342. https:\/\/doi.org\/10.3109\/01460869509087271.","journal-title":"J Sch Nurs"},{"key":"652_CR3","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejpn.2017.02.003","volume":"21","author":"B Chen","year":"2017","unstructured":"Chen B, Detyniecki K, Choi H, et al. Psychiatric and behavioral side effects of anti-epileptic drugs in adolescents and children with epilepsy. Eur J Paediatr Neurol. 2017;21:441\u20139. https:\/\/doi.org\/10.1016\/j.ejpn.2017.02.003.","journal-title":"Eur J Paediatr Neurol"},{"key":"652_CR4","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1212\/01.wnl.0000247045.85646.c0","volume":"67","author":"AB Ettinger","year":"2006","unstructured":"Ettinger AB. Psychotropic effects of antiepileptic drugs. Neurology. 2006;67:1916\u201325. https:\/\/doi.org\/10.1212\/01.wnl.0000247045.85646.c0.","journal-title":"Neurology"},{"key":"652_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.yebeh.2017.04.003","volume":"71","author":"LJ Stephen","year":"2017","unstructured":"Stephen LJ, Wishart A, Brodie MJ. Psychiatric side effects and antiepileptic drugs: observations from prospective audits. Epilepsy Behav. 2017;71:73\u20138. https:\/\/doi.org\/10.1016\/j.yebeh.2017.04.003.","journal-title":"Epilepsy Behav"},{"issue":"10","key":"652_CR6","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s40263-022-00955-9","volume":"36","author":"A Strzelczyk","year":"2022","unstructured":"Strzelczyk A, Schubert-Bast S. Psychobehavioural and cognitive adverse events of anti-seizure medications for the treatment of developmental and epileptic encephalopathies. CNS Drugs. 2022;36(10):1079\u2013111. https:\/\/doi.org\/10.1007\/s40263-022-00955-9.","journal-title":"CNS Drugs"},{"key":"652_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2019.106856","volume":"104","author":"JM Welton","year":"2020","unstructured":"Welton JM, Walker C, Riney K, et al. Quality of life and its association with comorbidities and adverse events from antiepileptic medications: online survey of patients with epilepsy in Australia. Epilepsy Behav. 2020;104: 106856. https:\/\/doi.org\/10.1016\/j.yebeh.2019.106856.","journal-title":"Epilepsy Behav"},{"issue":"3","key":"652_CR8","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.seizure.2013.11.009","volume":"23","author":"RJ de Kinderen","year":"2014","unstructured":"de Kinderen RJ, Evers SM, Rinkens R, et al. Side-efects of antiepileptic drugs: the economic burden. Seizure. 2014;23(3):184\u201390. https:\/\/doi.org\/10.1016\/j.seizure.2013.11.009.","journal-title":"Seizure."},{"key":"652_CR9","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association Publishing; 2013.","edition":"5"},{"key":"652_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/00004583-200203000-00004","volume":"41","author":"DF Connor","year":"2002","unstructured":"Connor DF, Glatt SJ, Lopez ID, et al. Psychopharmacology and aggression. I: a meta-analysis of stimulant effects on overt\/covert aggression-related behaviors in ADHD. J Am Acad Child Adolesc Psychiatry. 2002;41:253\u201361. https:\/\/doi.org\/10.1097\/00004583-200203000-00004.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"9","key":"652_CR11","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1176\/appi.ajp.2009.08121849","volume":"166","author":"A Stringaris","year":"2009","unstructured":"Stringaris A, Cohen P, Pine DS, et al. Adult outcomes of youth irritability: a 20-year prospective community-based study. Am J Psychiatry. 2009;166(9):1048\u201354. https:\/\/doi.org\/10.1176\/appi.ajp.2009.08121849.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"652_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.12603","volume":"22","author":"M Mula","year":"2015","unstructured":"Mula M, Cock HR. More than seizures: improving the lives of people with refractory epilepsy. Eur J Neurol. 2015;22(1):24\u201330. https:\/\/doi.org\/10.1111\/ene.12603.","journal-title":"Eur J Neurol"},{"issue":"4","key":"652_CR13","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/epi.13709","volume":"58","author":"IE Scheffer","year":"2017","unstructured":"Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512\u201321. https:\/\/doi.org\/10.1111\/epi.13709.","journal-title":"Epilepsia"},{"key":"652_CR14","doi-asserted-by":"publisher","DOI":"10.5080\/u23408","author":"F \u00dcnal","year":"2019","unstructured":"\u00dcnal F, \u00d6ktem F, \u00c7etin \u00c7uhadaro\u011flu F, et al. Reliability and validity of the schedule for affective disorders and schizophrenia for school-age children-present and lifetime version, DSM-5 November 2016-Turkish adaptation (K-SADS-PL-DSM-5-T). Turk J Psychiatry. 2019. https:\/\/doi.org\/10.5080\/u23408.","journal-title":"Turk J Psychiatry"},{"key":"652_CR15","doi-asserted-by":"publisher","unstructured":"Spielberger CD. State\u2010Trait anger expression inventory.\u00a0The Corsini encyclopedia of psychology. 2010, pp. 1\u20131. https:\/\/doi.org\/10.1002\/9780470479216.corpsy0942.","DOI":"10.1002\/9780470479216.corpsy0942"},{"key":"652_CR16","first-page":"26","volume":"9","author":"AK \u00d6zer","year":"1994","unstructured":"\u00d6zer AK. S\u00fcrekli \u00f6fke (SL-\u00d6fke) ve \u00f6fke ifade tarz\u0131 (\u00d6fke-tarz) \u00f6l\u00e7ekleri \u00f6n \u00e7al\u0131\u015fmas\u0131. T\u00fcrk Psikoloji Dergisi. 1994;9:26\u201335.","journal-title":"T\u00fcrk Psikoloji Dergisi."},{"key":"652_CR17","unstructured":"Turgay A. Disruptive behavior disorders child and adolescent screening and rating scales for children, adolescents, parents and teachers. West Bloomfield: Integrative Therapy Institute Publication; 1994."},{"key":"652_CR18","first-page":"132","volume":"8","author":"ES Ercan","year":"2001","unstructured":"Ercan ES, Amado S, Somer O, \u00c7\u0131ko\u011flu S. Dikkat eksikli\u011fi hiperaktivite bozuklu\u011fu ve y\u0131k\u0131c\u0131 davran\u0131m bozukluklar\u0131 i\u00e7in bir test bataryas\u0131 geli\u015ftirme \u00e7abas\u0131. \u00c7ocuk Gen\u00e7lik Ruh Sa\u011fl\u0131\u011f\u0131 Derg. 2001;8:132\u201344.","journal-title":"\u00c7ocuk Gen\u00e7lik Ruh Sa\u011fl\u0131\u011f\u0131 Derg."},{"issue":"1","key":"652_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ejpn.2013.07.003","volume":"18","author":"C Dureau-Pournin","year":"2014","unstructured":"Dureau-Pournin C, P\u00e9despan JM, Droz-Perroteau C, et al. Continuation rates of levetiracetam in children from the EULEVp cohort study. Eur J Paediatr Neurol. 2014;18(1):19\u201324. https:\/\/doi.org\/10.1016\/j.ejpn.2013.07.003.","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"652_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ejpn.2014.11.001","volume":"19","author":"XF Feng","year":"2015","unstructured":"Feng XF, Chen YX, Liu L, et al. Retention rates of levetiraceram in Chinese children and adolescents with epilepsy. Eur J Paediatr Neurol. 2015;19(2):143\u20138. https:\/\/doi.org\/10.1016\/j.ejpn.2014.11.001.","journal-title":"Eur J Paediatr Neurol"},{"issue":"7","key":"652_CR21","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00228-017-2245-z","volume":"73","author":"G Zaccara","year":"2017","unstructured":"Zaccara G, Giovannelli F, Giorgi FS, et al. Tolerability of new antiepileptic drugs: a network meta-analysis. Eur J Clin Pharmacol. 2017;73(7):811\u20137. https:\/\/doi.org\/10.1007\/s00228-017-2245-z.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"652_CR22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.seizure.2004.10.004","volume":"14","author":"L Lagae","year":"2005","unstructured":"Lagae L, Buyse G, Ceulemans B. Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial. Seizure. 2005;14(1):66\u201371. https:\/\/doi.org\/10.1016\/j.seizure.2004.10.004.","journal-title":"Seizure."},{"issue":"4","key":"652_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ejpn.2007.09.004","volume":"12","author":"PM Callenbach","year":"2008","unstructured":"Callenbach PM, Arts WF, Ten HR, et al. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study. Eur J Paediatr Neurol. 2008;12(4):321\u20137. https:\/\/doi.org\/10.1016\/j.ejpn.2007.09.004.","journal-title":"Eur J Paediatr Neurol"},{"issue":"4","key":"652_CR24","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.seizure.2005.02.004","volume":"14","author":"S Grosso","year":"2005","unstructured":"Grosso S, Franzoni E, Coppola G, et al. Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy. Seizure. 2005;14(4):248\u201353. https:\/\/doi.org\/10.1016\/j.seizure.2005.02.004.","journal-title":"Seizure."},{"issue":"2","key":"652_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.seizure.2006.12.001","volume":"16","author":"D Peake","year":"2007","unstructured":"Peake D, Mordekar S, Gosalakkal J, et al. Retention rate of levetiracetam in children with intractable epilepsy at 1 year. Seizure. 2007;16(2):185\u20139. https:\/\/doi.org\/10.1016\/j.seizure.2006.12.001.","journal-title":"Seizure."},{"issue":"3","key":"652_CR26","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.yebeh.2010.04.017","volume":"18","author":"C de la Loge","year":"2010","unstructured":"de la Loge C, Hunter SJ, Schiemann J, et al. Assessment of behavioral and emotional functioning using standardized instruments in children and adolescents with partial-onset seizures treated with adjunctive levetiracetam in a randomized, placebo-controlled trial. Epilepsy Behav. 2010;18(3):291\u20138. https:\/\/doi.org\/10.1016\/j.yebeh.2010.04.017.","journal-title":"Epilepsy Behav"},{"key":"652_CR27","first-page":"272","volume":"47","author":"M Matsuo","year":"2015","unstructured":"Matsuo M, Fuji A, Matsuzaka T, et al. Effectiveness and safety of long-term levetiracetam treatment in patients with refractory epilepsy. No To Hattatsu. 2015;47:272\u20138.","journal-title":"No To Hattatsu"},{"key":"652_CR28","unstructured":"Depakene (valproic acid). Prescribing information. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/01808.1s065_018082s048lbl.pdf. Accessed 29 Aug 2022."},{"key":"652_CR29","unstructured":"Epilim (sodium valproate). Summary of product characteristics. https:\/\/www.medicines.org.uk\/emc\/product\/1446\/smpc#gref. Accessed 29 Aug 2022."},{"key":"652_CR30","doi-asserted-by":"publisher","first-page":"738","DOI":"10.4088\/JCP.v65n0601","volume":"65","author":"SM Stahl","year":"2004","unstructured":"Stahl SM. Anticonvulsants as mood stabilizers and adjuncts to antipsychotics: valproate, lamotrigine, carbamazepine, and oxcarbazepine and actions at voltage gated sodium channels. J Clin Psychiatry. 2004;65:738\u20139.","journal-title":"J Clin Psychiatry"},{"key":"652_CR31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yebeh.2017.08.039","volume":"76","author":"B Chen","year":"2017","unstructured":"Chen B, Choi H, Hirsch LJ, et al. Psychiatric and behavioral side efects of antiepileptic drugs in adults with epilepsy. Epilepsy Behav. 2017;76:24\u201331. https:\/\/doi.org\/10.1016\/j.yebeh.2017.08.039.","journal-title":"Epilepsy Behav"},{"key":"652_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.yebeh.2015.04.048","volume":"47","author":"S Realmuto","year":"2015","unstructured":"Realmuto S, Zummo L, Cerami C, et al. Social cognition dysfunctions in patients with epilepsy: evidence from patients with temporal lobe and idiopathic generalized epilepsies. Epilepsy Behav. 2015;47:98\u2013103. https:\/\/doi.org\/10.1016\/j.yebeh.2015.04.048.","journal-title":"Epilepsy Behav"},{"issue":"1\u20132","key":"652_CR33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000347230","volume":"70","author":"DL Koo","year":"2013","unstructured":"Koo DL, Hwang KJ, Kim D, et al. Effects of levetiracetam monotherapy on the cognitive function of epilepsy patients. Eur Neurol. 2013;70(1\u20132):88\u201394. https:\/\/doi.org\/10.1159\/000347230.","journal-title":"Eur Neurol"},{"issue":"7","key":"652_CR34","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.seizure.2011.04.004","volume":"20","author":"LJ Stephen","year":"2011","unstructured":"Stephen LJ, Kelly K, Parker P, et al. Levetiracetam monotherapy\u2014outcomes from an epilepsy clinic. Seizure. 2011;20(7):554\u20137. https:\/\/doi.org\/10.1016\/j.seizure.2011.04.004.","journal-title":"Seizure."},{"issue":"4","key":"652_CR35","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1684\/epd.2008.0227","volume":"10","author":"M Lopez-Gongora","year":"2008","unstructured":"Lopez-Gongora M, Martinez-Domerio A, Garcia C, et al. Effect of levetiracetam on cognitive functions and quality of life: a one-year follow-up study. Epileptic Disord. 2008;10(4):297\u2013305. https:\/\/doi.org\/10.1684\/epd.2008.0227.","journal-title":"Epileptic Disord"},{"issue":"1","key":"652_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1059-1311(03)00111-0","volume":"13","author":"M Mula","year":"2004","unstructured":"Mula M, Trimble MR, Sander JW. Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam. Seizure. 2004;13(1):55\u20137. https:\/\/doi.org\/10.1016\/S1059-1311(03)00111-0.","journal-title":"Seizure."},{"key":"652_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-002564","volume":"3","author":"UC Wieshmann","year":"2013","unstructured":"Wieshmann UC, Baker GA. Self-reported feelings of anger and aggression towards others in patients on levetiracetam: data from the UK antiepileptic drug register. BMJ Open. 2013;3: e002564. https:\/\/doi.org\/10.1136\/bmjopen-2013-002564.","journal-title":"BMJ Open"},{"issue":"3","key":"652_CR38","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1528-1167.2008.01792.x","volume":"50","author":"DM Labiner","year":"2009","unstructured":"Labiner DM, Ettinger AB, Fakhoury TA, et al. Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy. Epilepsia. 2009;50(3):434\u201342. https:\/\/doi.org\/10.1111\/j.1528-1167.2008.01792.x.","journal-title":"Epilepsia"},{"issue":"3","key":"652_CR39","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s40272-021-00448-0","volume":"23","author":"FMC Besag","year":"2021","unstructured":"Besag FMC, Vasey MJ. Neurocognitive effects of antiseizure medications in children and adolescents with epilepsy. Pediatr Drugs. 2021;23(3):253\u201386. https:\/\/doi.org\/10.1007\/s40272-021-00448-0.","journal-title":"Pediatr Drugs"},{"issue":"6","key":"652_CR40","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.braindev.2017.01.006","volume":"39","author":"R Moavero","year":"2017","unstructured":"Moavero R, Santarone ME, Galasso C, et al. Cognitive and behavioral efects of new antiepileptic drugs in pediatric epilepsy. Brain Dev. 2017;39(6):464\u20139. https:\/\/doi.org\/10.1016\/j.braindev.2017.01.006.","journal-title":"Brain Dev"},{"issue":"4","key":"652_CR41","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.spen.2017.10.011","volume":"24","author":"A Ulate-Campos","year":"2017","unstructured":"Ulate-Campos A, Fern\u00e1ndez IS. Cognitive and behavioral comorbidities: an unwanted efect of antiepileptic drugs in children. Semin Pediatr Neurol. 2017;24(4):320\u201330. https:\/\/doi.org\/10.1016\/j.spen.2017.10.011.","journal-title":"Semin Pediatr Neurol."},{"issue":"11","key":"652_CR42","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1111\/j.1528-1167.2009.02197.x","volume":"50","author":"PM Levisohn","year":"2009","unstructured":"Levisohn PM, Mintz M, Hunter SJ, et al. Neurocognitive efects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial. Epilepsia. 2009;50(11):2377\u201389. https:\/\/doi.org\/10.1111\/j.1528-1167.2009.02197.x.","journal-title":"Epilepsia"},{"issue":"1","key":"652_CR43","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1177\/0883073811417183","volume":"27","author":"J Schiemann-Delgado","year":"2012","unstructured":"Schiemann-Delgado J, Yang H, Loge Cde L, et al. A long-term open-label extension study assessing cognition and behavior, tolerability, safety, and eficacy of adjunctive levetiracetam in children aged 4 to 16 years with partial-onset seizures. J Child Neurol. 2012;27(1):80\u20139. https:\/\/doi.org\/10.1177\/0883073811417183.","journal-title":"J Child Neurol"},{"key":"652_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40261-017-0585-1","volume":"38","author":"A Verrotti","year":"2018","unstructured":"Verrotti A, Moavero R, Panzarino G, et al. The challenge of pharmacotherapy in children and adolescents with epilepsy-ADHD comorbidity. Clin Drug Investig. 2018;38:1\u20138. https:\/\/doi.org\/10.1007\/s40261-017-0585-1.","journal-title":"Clin Drug Investig"},{"key":"652_CR45","doi-asserted-by":"publisher","unstructured":"Auvin S, Wirrell E, Donald KA, et al. Systematic review of the screening, diagnosis, and management of ADHD in children with epilepsy. Consensus paper of the Task Force on Comorbidities of the ILAE Pediatric Commission. Epilepsia. 2018;59(10):1867\u201380. https:\/\/doi.org\/10.1111\/epi.14549.","DOI":"10.1111\/epi.14549"},{"key":"652_CR46","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.seizure.2018.09.014","volume":"62","author":"B Chen","year":"2018","unstructured":"Chen B, Choi H, Hirsch LJ, et al. Cross-sensitivity of psychiatric and behavioral side effects with antiepileptic drug use. Seizure. 2018;62:38\u201342. https:\/\/doi.org\/10.1016\/j.seizure.2018.09.014.","journal-title":"Seizure."}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-024-00652-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-024-00652-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-024-00652-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T15:05:21Z","timestamp":1730127921000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-024-00652-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["652"],"URL":"https:\/\/doi.org\/10.1007\/s40272-024-00652-8","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"25 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was obtained for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"None of the authors have any conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study received ethics committee approval from the Health Sciences University Kartal Dr. L\u00fctfi K\u0131rdar City Hospital (no. 2021-514-214-2).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants provided consent to participate in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors made substantive contributions to the study design and manuscript. ZVP wrote the first draft and all authors provided input into revising the article. All authors revised and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}